| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |